Crinetics (CRNX) PT Raised to $97 at Citizens on Palsonify's EU Approval
Tweet Send to a Friend
Citizens analyst Jonathan Wolleben raised the price target on Crinetics (NASDAQ: CRNX) to $97.00 (from $96.00) while maintaining a Market ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
